Internal Medicine · Crisfield, MD
NPI
1174589386
Since 2006
Specialty
Internal Medicine
Code 207R00000X
Group practices
3
Medicare group memberships
Hospitals
2
Hospital affiliations
201 Hall Highway
Crisfield, MD, 21817
Phone (410) 968-1200
Groups this clinician bills Medicare through
Medicare paid, 2024
$159K
2,744 services
Medicare patients, 2024
573
Average age 75
Drug cost, 2024
$2.8M
24,062 prescriptions
Company payments, 2025
$1,129
From 19 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Vijaykumar Karumbunathan was code 99214 (office e&m - established), 643 times for 312 patients. In total Vijaykumar Karumbunathan billed 2,744 services in 30 codes, and Medicare paid $159K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2008-06-19.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 643 | 312 | $42.11 | $27K |
| 99309 SNF E&M | Facility | 472 | 100 | $78.36 | $37K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 340 | 230 | $12.64 | $4,296 |
| 99308 SNF E&M | Facility | 339 | 79 | $53.38 | $18K |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Facility | 236 | 236 | $128.81 | $30K |
| 99213 Office E&M - Established | Facility | 234 | 176 | $23.01 | $5,383 |
| 99495 Chronic, Principal, and Transitional Care Management | Facility | 60 | 51 | $103.99 | $6,239 |
| 99232 Hospital E&M - Subsequent | Facility | 55 | 40 | $58.65 | $3,226 |
| 99306 SNF E&M | Facility | 47 | 43 | $139.50 | $6,556 |
| 99233 Hospital E&M - Subsequent | Facility | 45 | 36 | $91.15 | $4,102 |
| 92228 Computerized Ophthalmic Imaging | Facility | 38 | 38 | $9.53 | $362 |
| 99305 SNF E&M | Facility | 37 | 35 | $102.78 | $3,803 |
| 99315 SNF E&M | Facility | 32 | 31 | $60.27 | $1,929 |
| 20610 Joint Injection | Facility | 31 | 22 | $34.58 | $1,072 |
| G0402 Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Facility | 19 | 19 | $128.46 | $2,441 |
By year: 2022 $185K for 2,878 services; 2023 $168K for 2,509 services; 2024 $159K for 2,744 services.
Medicare prescription drug claims, 2024
In 2024, the drug Vijaykumar Karumbunathan prescribed most often to Medicare patients was Atorvastatin Calcium, with 1,366 prescriptions and refills. In total Vijaykumar Karumbunathan wrote 24,062 Medicare prescriptions that cost $2.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 1,366 | 2,476 | 274 | $19K |
| Eliquis Apixaban | 854 | 962 | 87 | $409K |
| Amlodipine Besylate Generic | 817 | 1,563 | 170 | $6,084 |
| Losartan Potassium Generic | 739 | 1,441 | 171 | $8,812 |
| Levothyroxine Sodium Generic | 715 | 1,145 | 106 | $6,526 |
| Pantoprazole Sodium Generic | 697 | 1,106 | 153 | $9,678 |
| Jardiance Empagliflozin | 495 | 585 | 70 | $291K |
| Potassium Chloride Generic | 475 | 724 | 103 | $6,624 |
| Carvedilol Generic | 459 | 644 | 77 | $3,445 |
| Metoprolol Succinate Generic | 453 | 894 | 102 | $7,380 |
| Hydralazine Hcl Generic | 443 | 592 | 73 | $6,341 |
| Rosuvastatin Calcium Generic | 433 | 852 | 99 | $7,965 |
| Gabapentin Generic | 423 | 543 | 77 | $6,847 |
| Torsemide Generic | 399 | 539 | 73 | $4,887 |
| Furosemide Generic | 390 | 588 | 81 | $2,592 |
Brand drugs: 5,177 claims; generic drugs: 18,766 claims; opioid claims: 229.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Vijaykumar Karumbunathan $1,129 ($1,129 in general payments such as food, travel and fees) from 19 companies. The largest payer was Abbvie Inc. with $183.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 17 | $183 |
| Scpharmaceuticals Inc. SCPH | 6 | $97.99 |
| Pfizer Inc. PFE | 5 | $94.13 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 5 | $91.09 |
| Novo Nordisk Inc NVO | 4 | $71.09 |
| UCB, Inc. UCB.BR | 3 | $67.63 |
| AstraZeneca Pharmaceuticals LP AZN | 3 | $65.94 |
| Lundbeck LLC | 3 | $60.27 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) JNJ | 3 | $55.02 |
| Exact Sciences Corporation EXAS | 2 | $45.18 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.